study

Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease

MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative…

3 months ago

9 in 10 CEOs See a Stronger Business Case for Sustainability; Nearly All Plan to Maintain or Expand Commitments, UN Global Compact-Accenture 2025 CEO Study Finds

CEOs call for a new era of pragmatic execution that embeds sustainability in strategy and culture (96%), but warn of…

3 months ago

RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma

Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to advance innovative Theranostic radiopharmaceuticals to address unmet needs…

3 months ago

Booking Health Expands Access to Dendritic Cell Therapy After Study Confirms Survival Benefit in Glioblastoma Patients

September 09, 2025 13:19 ET  | Source: Booking Health Langenfeld, Germany, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Booking Health, a…

3 months ago

Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”

WASHINGTON, DC, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Informed Consent Action Network (ICAN), led by Emmy Award-winning producer and…

3 months ago

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

September 06, 2025 14:30 ET  | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…

3 months ago

Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community

SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the…

3 months ago

Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease

Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…

3 months ago

Outliyr Releases Biological Age Testing Case Study Revealing 13.1-Year Variation Across Seven Products

Austin, TX, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Outliyr, a platform for high-performance Bio-Optimization, today released the results of an…

3 months ago

IBM Study: Sports Fans Demand More Dynamic Digital Content, Powered by AI

Most fans surveyed agree that AI-powered features will have a significant impact on how they consume sports More than half surveyed…

4 months ago